Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2026, Vol. 31 ›› Issue (10): 1430-1440.doi: 10.12092/j.issn.1009-2501.2026.10.014
Haobo GAO1(
), Hifsa Bibi1, Pengcheng ZHU1, Hongtu TAN1, Tao WU2,*(
)
Received:2025-05-12
Revised:2025-10-26
Online:2026-10-26
Published:2026-11-11
Contact:
Tao WU
E-mail:gaohaobo8128@163.com;wutao@hactcm.edu.cn
CLC Number:
Haobo GAO, Hifsa Bibi, Pengcheng ZHU, Hongtu TAN, Tao WU. Research progress of drugs in the treatment of cerebral ischemia-reperfusion injury through the JNK signaling pathway[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(10): 1430-1440.
| 药物名称 | 药物英文名称 | 实验模型 | 药理作用机制 | 作用 |
| 安菲博肽 | Anfibatide | SD大鼠 | 抑制TLR4/JNK信号通路,下调 TLR4、p-JNK、NF-κB,降低 IL-1β、IL-6、TNF-α 水平 | 减轻神经功能缺损,缩小脑梗死体积,改善组织病理学损伤,抑制神经元凋亡 |
| 高压氧治疗 | Hyperbaric Oxygen Therapy | SD大鼠 | 调控铁死亡通路,下调 PTGS2、IREB2、ACSL4、TFR1、LPCAT3、JNK、p-JNK、p-ERK、MEK 表达,上调 SLC7A11、FTL、FTH1、GPX4、Nrf2 表达,减轻线粒体损伤 | 改善记忆能力,增强 β-tubulin 表达,减轻神经元损伤,抑制铁死亡 |
| 二甲双胍 | Metformin | C57BL/6 小鼠, HT22 神经元细胞 | 抑制凋亡信号通路、JNK磷酸化,上调 Bcl-2、下调 Bax 及 Caspase-3 表达,降低 IL-1β、IL-18 等炎症因子水平 | 减少神经元凋亡,缩小脑梗死体积,降低脑水肿 |
| Apelin-12 | Apelin-12 | CD-1 小鼠 | 下调p-JNK、Bax表达,上调 Bcl-2 表达,降低 Bax/Bcl-2 比值,抑制凋亡 通路 | 改善神经功能评分,减轻脑水肿与神经元损伤,降低MDA、LDH,抑制神经细胞凋亡 |
| 白皮杉 | Piceatannol | Swiss albino 小鼠 | 抑制 JNK3 磷酸化、下调 p-JNK3、上调 Bcl-2 和 eNOS 基因表达、下调 Bax、c-Jun、cyt-c 和 iNOS 表达,阻断线粒体凋亡途径 | 增加脑血流量,改善运动和记忆功能,抑制神经元凋亡,减轻脑缺血再灌注损伤 |
| 丁基苯酞 | Butylphthalide | SD 大鼠 | 下调 p-JNK、p-c-Jun、FasL、p-Bcl-2 及 cleaved-caspase-3 表达,抑制 JNK–caspase-3 凋亡通路 | 减少海马 CA1 区神经元凋亡,减轻脑缺血/再灌注损伤,改善神经功能 |
| 食欲素-A | Orexin-A | SD 大鼠 | 抑制内质网应激介导的神经元凋亡,下调 GRP78、p-PERK、p-eIF2α、p-IRE1α、p-JNK、CHOP、cleaved caspase-12 和 cleaved caspase-3 表达 | 减少脑梗死体积,改善神经功能缺损评分 |
| 红花提取物乙酰谷酰胺 | SAAG | SD 大鼠 | 增强 GSH、Trx、Nrf2 三重抗氧化系统,抑制 ASK1-JNK/p38 级联反应,下调 p-ASK1、p-JNK、p-p38、cleaved-caspase-3 与 Bax,上调 Bcl-2 | 缩小脑梗死体积,减少细胞凋亡与氧化损伤 |
| 鸡血藤提取物 | Spatholobi Caulis | SD 大鼠 | 抑制 JNK 和 p38MAPK 磷酸化,下调 PARP、caspase-3、p-p53 表达,上调 BDNF 表达,降低 ROS 水平 | 减少神经元凋亡,抑制胶质细胞激活及氧化应激 |
| 罗氟司特 | Roflumilast | SD 大鼠 | 促进 Nrf-2 核转位,抑制 ROS 生成;阻断 IRE1α/TRAF2 复合物形成,下调 p-IRE1α、p-JNK,减少凋亡 | 减轻氧化应激,缩小脑梗死体积,减少神经元凋亡 |
| β-细辛醚 | β-Asarone | SD 大鼠 | 下调 JNK、p-JNK 和 Beclin-1 表达,上调 Bcl-2 表达,阻断 JNK-Bcl-2-Beclin-1 介导的自噬通路 | 抑制过度自噬,降低血清神经元特异性烯醇化酶,减小梗死体积 |
| 生脉散复方 | SMXZF | C57BL/6 小鼠 | 下调 Beclin-1、LC3-II/LC3-I,抑制 AMPK 磷酸化,促进 mTOR 磷酸化,抑制 JNK 磷酸化 | 减轻脑水肿,恢复脑血流,抑制过度自噬 |
| 双特异性磷酸酶10 | DUSP10 | C57BL/6J 小鼠 | 下调 p-p38、p-JNK、Bax表达,上调 Bcl-2 表达,降低 Bax/Bcl-2 水平,抑制 p38/JNK 介导的神经元凋亡 | 减少神经元凋亡,改善缺血性脑损伤 |
Table 1 Research on the therapeutic effects of apoptosis in CIRI by drugs regulating the JNK signaling pathway
| 药物名称 | 药物英文名称 | 实验模型 | 药理作用机制 | 作用 |
| 安菲博肽 | Anfibatide | SD大鼠 | 抑制TLR4/JNK信号通路,下调 TLR4、p-JNK、NF-κB,降低 IL-1β、IL-6、TNF-α 水平 | 减轻神经功能缺损,缩小脑梗死体积,改善组织病理学损伤,抑制神经元凋亡 |
| 高压氧治疗 | Hyperbaric Oxygen Therapy | SD大鼠 | 调控铁死亡通路,下调 PTGS2、IREB2、ACSL4、TFR1、LPCAT3、JNK、p-JNK、p-ERK、MEK 表达,上调 SLC7A11、FTL、FTH1、GPX4、Nrf2 表达,减轻线粒体损伤 | 改善记忆能力,增强 β-tubulin 表达,减轻神经元损伤,抑制铁死亡 |
| 二甲双胍 | Metformin | C57BL/6 小鼠, HT22 神经元细胞 | 抑制凋亡信号通路、JNK磷酸化,上调 Bcl-2、下调 Bax 及 Caspase-3 表达,降低 IL-1β、IL-18 等炎症因子水平 | 减少神经元凋亡,缩小脑梗死体积,降低脑水肿 |
| Apelin-12 | Apelin-12 | CD-1 小鼠 | 下调p-JNK、Bax表达,上调 Bcl-2 表达,降低 Bax/Bcl-2 比值,抑制凋亡 通路 | 改善神经功能评分,减轻脑水肿与神经元损伤,降低MDA、LDH,抑制神经细胞凋亡 |
| 白皮杉 | Piceatannol | Swiss albino 小鼠 | 抑制 JNK3 磷酸化、下调 p-JNK3、上调 Bcl-2 和 eNOS 基因表达、下调 Bax、c-Jun、cyt-c 和 iNOS 表达,阻断线粒体凋亡途径 | 增加脑血流量,改善运动和记忆功能,抑制神经元凋亡,减轻脑缺血再灌注损伤 |
| 丁基苯酞 | Butylphthalide | SD 大鼠 | 下调 p-JNK、p-c-Jun、FasL、p-Bcl-2 及 cleaved-caspase-3 表达,抑制 JNK–caspase-3 凋亡通路 | 减少海马 CA1 区神经元凋亡,减轻脑缺血/再灌注损伤,改善神经功能 |
| 食欲素-A | Orexin-A | SD 大鼠 | 抑制内质网应激介导的神经元凋亡,下调 GRP78、p-PERK、p-eIF2α、p-IRE1α、p-JNK、CHOP、cleaved caspase-12 和 cleaved caspase-3 表达 | 减少脑梗死体积,改善神经功能缺损评分 |
| 红花提取物乙酰谷酰胺 | SAAG | SD 大鼠 | 增强 GSH、Trx、Nrf2 三重抗氧化系统,抑制 ASK1-JNK/p38 级联反应,下调 p-ASK1、p-JNK、p-p38、cleaved-caspase-3 与 Bax,上调 Bcl-2 | 缩小脑梗死体积,减少细胞凋亡与氧化损伤 |
| 鸡血藤提取物 | Spatholobi Caulis | SD 大鼠 | 抑制 JNK 和 p38MAPK 磷酸化,下调 PARP、caspase-3、p-p53 表达,上调 BDNF 表达,降低 ROS 水平 | 减少神经元凋亡,抑制胶质细胞激活及氧化应激 |
| 罗氟司特 | Roflumilast | SD 大鼠 | 促进 Nrf-2 核转位,抑制 ROS 生成;阻断 IRE1α/TRAF2 复合物形成,下调 p-IRE1α、p-JNK,减少凋亡 | 减轻氧化应激,缩小脑梗死体积,减少神经元凋亡 |
| β-细辛醚 | β-Asarone | SD 大鼠 | 下调 JNK、p-JNK 和 Beclin-1 表达,上调 Bcl-2 表达,阻断 JNK-Bcl-2-Beclin-1 介导的自噬通路 | 抑制过度自噬,降低血清神经元特异性烯醇化酶,减小梗死体积 |
| 生脉散复方 | SMXZF | C57BL/6 小鼠 | 下调 Beclin-1、LC3-II/LC3-I,抑制 AMPK 磷酸化,促进 mTOR 磷酸化,抑制 JNK 磷酸化 | 减轻脑水肿,恢复脑血流,抑制过度自噬 |
| 双特异性磷酸酶10 | DUSP10 | C57BL/6J 小鼠 | 下调 p-p38、p-JNK、Bax表达,上调 Bcl-2 表达,降低 Bax/Bcl-2 水平,抑制 p38/JNK 介导的神经元凋亡 | 减少神经元凋亡,改善缺血性脑损伤 |
| 药物名称 | 药物英文名称 | 实验模型 | 药理作用 | 对血脑屏障作用 |
| 石菖蒲 | Acorus tatarinowii Schott | SD 大鼠 | 下调AQP4、p-JNK、iNOS、ICAM-1、MMP-9、VEGF-A 表达,抑制 JNK/iNOS 介导的炎症级联;上调 ZO-3 | 减轻脑水肿,缩小梗死体积,降低血脑屏障通透性 |
| 右美托咪定 | Dexmedetomidine | SD 大鼠 | 抑制JNK磷酸化,下调 MMP-9活性及 iNOS/CD86,上调 ZO-1、claudin-5、occludin 和 AQP-4,促进 M2 型小胶质极化 | 减轻血脑屏障破坏,缩小脑梗死体积,降低脑水肿,抑制神经炎症 |
| MicroRNA-152-3p | miR-152-3p | SD 大鼠 | 抑制MAP3K2表达阻断MAP3K2/JNK通路,降低 JNK的磷酸化水平 | 减轻血脑屏障破坏,缩小脑梗死体积,减少内皮细胞凋亡 |
| 3-正丁苯酞 | 3-n-butylphthalide | SD 大鼠 | 抑制p38MAPK、JNK 磷酸化,减少 ROS 和 MDA 生成,提升 SOD 活性 | 缩小脑梗死体积,减轻脑水肿,抑制神经元凋亡,改善氧化应激和血脑屏障完整性 |
| 左氧氟沙星 | Levofloxacin | C57BL/6 雄性小鼠 | 结合A-FABP 的 Asp76/Gln95/Arg126 位点,抑制 A-FABP-JNK/c-Jun 轴,下调 MMP-9 表达与活性,减少基质-紧密连接蛋白降解,抑制中性粒细胞与白细胞浸润 | 减轻血脑屏障破坏,缩小脑梗死体积,降低神经炎症 |
| 茴香脑 | Anethole | SD 大鼠 | 下调 p-JNK、p-p38、MMP-2、MMP-9、NF-κB、iNOS、NO、Bax 表达,上调 Bcl-2、SOD、CAT、GSH/GSSG 比值,降低 MDA、TNF-α、IL-1β、IL-6 水平 | 保护血脑屏障,抑制神经元变性,减轻氧化应激、炎症与细胞凋亡 |
Table 2 Research on the therapeutic effects of the blood-brain barrier in CIRI by drugs regulating the JNK signaling pathway
| 药物名称 | 药物英文名称 | 实验模型 | 药理作用 | 对血脑屏障作用 |
| 石菖蒲 | Acorus tatarinowii Schott | SD 大鼠 | 下调AQP4、p-JNK、iNOS、ICAM-1、MMP-9、VEGF-A 表达,抑制 JNK/iNOS 介导的炎症级联;上调 ZO-3 | 减轻脑水肿,缩小梗死体积,降低血脑屏障通透性 |
| 右美托咪定 | Dexmedetomidine | SD 大鼠 | 抑制JNK磷酸化,下调 MMP-9活性及 iNOS/CD86,上调 ZO-1、claudin-5、occludin 和 AQP-4,促进 M2 型小胶质极化 | 减轻血脑屏障破坏,缩小脑梗死体积,降低脑水肿,抑制神经炎症 |
| MicroRNA-152-3p | miR-152-3p | SD 大鼠 | 抑制MAP3K2表达阻断MAP3K2/JNK通路,降低 JNK的磷酸化水平 | 减轻血脑屏障破坏,缩小脑梗死体积,减少内皮细胞凋亡 |
| 3-正丁苯酞 | 3-n-butylphthalide | SD 大鼠 | 抑制p38MAPK、JNK 磷酸化,减少 ROS 和 MDA 生成,提升 SOD 活性 | 缩小脑梗死体积,减轻脑水肿,抑制神经元凋亡,改善氧化应激和血脑屏障完整性 |
| 左氧氟沙星 | Levofloxacin | C57BL/6 雄性小鼠 | 结合A-FABP 的 Asp76/Gln95/Arg126 位点,抑制 A-FABP-JNK/c-Jun 轴,下调 MMP-9 表达与活性,减少基质-紧密连接蛋白降解,抑制中性粒细胞与白细胞浸润 | 减轻血脑屏障破坏,缩小脑梗死体积,降低神经炎症 |
| 茴香脑 | Anethole | SD 大鼠 | 下调 p-JNK、p-p38、MMP-2、MMP-9、NF-κB、iNOS、NO、Bax 表达,上调 Bcl-2、SOD、CAT、GSH/GSSG 比值,降低 MDA、TNF-α、IL-1β、IL-6 水平 | 保护血脑屏障,抑制神经元变性,减轻氧化应激、炎症与细胞凋亡 |
| 药物名称 | 药物英文名称 | 实验模型 | 药理作用 | 对炎症反应作用 |
| 益智仁提取物 | YZR extract | SD 大鼠 | 下调 JNK 介导的 ASK1 相关炎症信号通路,降低 p-ASK1、ASK1、T3JAM、TRAF3、p-JNK/JNK、NF-κB、iNOS、COX-2、TNF-α、IL-6 表达 | 抑制小胶质细胞和星形胶质细胞活化,减轻神经炎症 |
| 环肽化合物 | Sparganin C | SD 大鼠 | 上调 JUNB、SOX5、SATB2、PI3K p85、p-Akt、Bcl-2、CD206、Arg-1 表达,下调 p-JNK、NF-κB、IKBKB、Bax、Caspase-3、TNF-α、IL-1β、CD40 表达,降低 Bax/Bcl-2 水平 | 抑制神经炎症,减轻氧化应激,缩小梗死体积,改善神经功能,促进小胶质细胞 M2 极化,减少细胞凋亡 |
| 血栓通注射液 (三七皂苷) | Xuesaitong injection (Panax notoginseng saponins) | SD大鼠 | 抑制JNK介导的JAK2/STAT3和NF-κB信号通路,降低炎症介质(IL-1β、IL-6、TNF-α、iNOS、COX-2、VCAM-1、MMP-2、MMP-9)表达,上调紧密连接蛋白ZO-1和occludin表达 | 改善脑微循环障碍,减轻神经功能缺损,减少脑梗死体积,抑制炎症反应 |
| 右美托咪定 | Dexmedetomidine | SD大鼠 | 抑制JNK信号通路的激活,下调Beclin-1、LC3-II/I和Caspase-3的表达,减少TNF-α、IL-6和IL-1β等炎症因子的释放 | 减少脑梗死体积,减轻神经元凋亡和病理损伤,降低自噬水平,抑制炎症反应 |
| 丹酚酸B | Salvianolic acid B | CD-1 雄性小鼠 | 下调 TLR4、p-p38MAPK、p-JNK、NF-κB 核转位及 IL-1β 表达,抑制 TLR4/MAPK/NF-κB 炎症信号通路 | 减少脑梗死体积,抑制神经炎症 |
| 酶体相关跨膜 蛋白5 | LAPTM5 | C57BL/6 小鼠 | 阻断ASK1-JNK/p38信号通路激活,下调NF-κB通路(降低p-IKKβ、p-p65,上调IκBα),减少促炎因子(TNF-α、IL-6、CCL-2、CCL-5)表达;上调抗凋亡蛋白Bcl-2,下调促凋亡蛋白Bax、cleaved-caspase-3及Fas表达 | 减轻脑缺血再灌注损伤,抑制神经元炎症反应和凋亡 |
| 紫苏醛 | Perilla aldehyde | SD大鼠 | 激活PI3K/Akt通路、抑制JNK磷酸化,下调Bax、caspase-3表达,降低NO/iNOS水平 | 减轻神经功能缺损,缩小脑梗死体积,减轻氧化应激,抑制细胞凋亡 |
Table 3 Research on the therapeutic effects of inflammation in CIRI by drugs regulating the JNK signaling pathway
| 药物名称 | 药物英文名称 | 实验模型 | 药理作用 | 对炎症反应作用 |
| 益智仁提取物 | YZR extract | SD 大鼠 | 下调 JNK 介导的 ASK1 相关炎症信号通路,降低 p-ASK1、ASK1、T3JAM、TRAF3、p-JNK/JNK、NF-κB、iNOS、COX-2、TNF-α、IL-6 表达 | 抑制小胶质细胞和星形胶质细胞活化,减轻神经炎症 |
| 环肽化合物 | Sparganin C | SD 大鼠 | 上调 JUNB、SOX5、SATB2、PI3K p85、p-Akt、Bcl-2、CD206、Arg-1 表达,下调 p-JNK、NF-κB、IKBKB、Bax、Caspase-3、TNF-α、IL-1β、CD40 表达,降低 Bax/Bcl-2 水平 | 抑制神经炎症,减轻氧化应激,缩小梗死体积,改善神经功能,促进小胶质细胞 M2 极化,减少细胞凋亡 |
| 血栓通注射液 (三七皂苷) | Xuesaitong injection (Panax notoginseng saponins) | SD大鼠 | 抑制JNK介导的JAK2/STAT3和NF-κB信号通路,降低炎症介质(IL-1β、IL-6、TNF-α、iNOS、COX-2、VCAM-1、MMP-2、MMP-9)表达,上调紧密连接蛋白ZO-1和occludin表达 | 改善脑微循环障碍,减轻神经功能缺损,减少脑梗死体积,抑制炎症反应 |
| 右美托咪定 | Dexmedetomidine | SD大鼠 | 抑制JNK信号通路的激活,下调Beclin-1、LC3-II/I和Caspase-3的表达,减少TNF-α、IL-6和IL-1β等炎症因子的释放 | 减少脑梗死体积,减轻神经元凋亡和病理损伤,降低自噬水平,抑制炎症反应 |
| 丹酚酸B | Salvianolic acid B | CD-1 雄性小鼠 | 下调 TLR4、p-p38MAPK、p-JNK、NF-κB 核转位及 IL-1β 表达,抑制 TLR4/MAPK/NF-κB 炎症信号通路 | 减少脑梗死体积,抑制神经炎症 |
| 酶体相关跨膜 蛋白5 | LAPTM5 | C57BL/6 小鼠 | 阻断ASK1-JNK/p38信号通路激活,下调NF-κB通路(降低p-IKKβ、p-p65,上调IκBα),减少促炎因子(TNF-α、IL-6、CCL-2、CCL-5)表达;上调抗凋亡蛋白Bcl-2,下调促凋亡蛋白Bax、cleaved-caspase-3及Fas表达 | 减轻脑缺血再灌注损伤,抑制神经元炎症反应和凋亡 |
| 紫苏醛 | Perilla aldehyde | SD大鼠 | 激活PI3K/Akt通路、抑制JNK磷酸化,下调Bax、caspase-3表达,降低NO/iNOS水平 | 减轻神经功能缺损,缩小脑梗死体积,减轻氧化应激,抑制细胞凋亡 |
| 1 |
Stoll G, Nieswandt B, Schuhmann MK. Ischemia/reperfusion injury in acute human and experimental stroke: focus on thrombo-inflammatory mechanisms and treatments[J]. Neurol Res Pract, 2024, 6 (1): 57.
doi: 10.1186/s42466-024-00355-y |
| 2 |
Plotnikov MB, Anishchenko AM, Khlebnikov AI, et al. Regulation of blood-brain barrier permeability via JNK signaling pathway: mechanisms and potential therapeutic strategies for ischemic stroke, Alzheimer’s disease and brain tumors[J]. Molecules, 2025, 30 (11): 2353.
doi: 10.3390/molecules30112353 |
| 3 |
李梅, 李强. 靶向Nrf2-铁死亡通路与缺血性脑卒中后脑损伤治疗研究进展[J]. 中国临床药理学与治疗学, 2024, 29 (2): 188- 197.
doi: 10.12092/j.issn.1009-2501.2024.02.009 |
| 4 |
Liu TL, Li XL, Zhou XW, et al. PI3K/AKT signaling and neuroprotection in ischemic stroke: molecular mechanisms and therapeutic perspectives[J]. Neural Regen Res, 2025, 20 (10): 2758- 2775.
doi: 10.4103/NRR.NRR-D-24-00568 |
| 5 |
Kumar P, Patel R, Shah SS, et al. Exploring the role of AMPK-JNK signaling pathways in Parkinson’s disease: pathophysiology to therapeutic strategies[J]. Neurosci Behav Physiol, 2025, 55 (1): 86- 100.
doi: 10.1007/s11055-025-01750-x |
| 6 |
赵敏菡, 储心乔, 曹晓慧, 等. 基于JNK信号通路调控细胞自噬探讨化浊解毒活血通络方对脑缺血再灌注损伤的保护作用[J]. 中国实验方剂学杂志, 2023, 29 (7): 115- 125.
doi: 10.13422/j.cnki.syfjx.20230793 |
| 7 |
李素萍, 许飞, 余能伟, 等. 莪术醇通过减轻大鼠氧化应激和海马神经元凋亡、抑制JNK1的活化保护大鼠脑缺血再灌注损伤[J]. 时珍国医国药, 2022, 33 (6): 1317- 1322.
doi: 10.3969/j.issn.1008-0805.2022.06.11 |
| 8 | 卜忠奇. Steap4促进脑缺血再灌注损伤中神经元铁死亡的机制研究 [D]. 中国医科大学, 2021. |
| 9 |
曾富康, 张宇星, 周德生, 等. 核心钟基因Bmal1通过JNK/caspase-3信号通路抑制缺血再灌注损伤PC12细胞的炎症及凋亡[J]. 中国病理生理杂志, 2022, 38 (11): 1972- 1980.
doi: 10.3969/j.issn.1000-4718.2022.11.007 |
| 10 |
Luo X, Niu JY, Chen HS. The potential value of traditional Chinese medicine monomers in cerebral ischemia-reperfusion injury: a network meta-analysis based on animal model[J]. BMC Complement Med Ther, 2025, 25 (1): 168.
doi: 10.1186/s12906-025-04898-8 |
| 11 |
Granger DN, Kvietys PR. Reperfusion injury and reactive oxygen species: the evolution of a concept[J]. Redox Biol, 2015, 6, 524- 551.
doi: 10.1016/j.redox.2015.08.020 |
| 12 |
Luo Q, Zheng J, Fan B, et al. Enriched environment attenuates ferroptosis after cerebral ischemia/reperfusion injury by regulating iron metabolism[J]. Brain Res Bull, 2023, 203, 110778.
doi: 10.1016/j.brainresbull.2023.110778 |
| 13 |
Mujanovic A, Ng F, Meinel TR, et al. No-reflow phenomenon in stroke patients: a systematic literature review and meta-analysis of clinical data[J]. Int J Stroke, 2024, 19 (1): 58- 67.
doi: 10.1177/17474930231180434 |
| 14 |
Lapi D, Colantuoni A. Remodeling of cerebral microcirculation after ischemia-reperfusion[J]. J Vasc Res, 2015, 52 (1): 22- 31.
doi: 10.1159/000381096 |
| 15 |
Li D, Zhang Y, Liu R, et al. Traditional Chinese medicine as a viable option for managing vascular cognitive impairment: a ray of hope[J]. Medicine (Baltimore), 2025, 104 (11): e41836.
doi: 10.1097/MD.0000000000041836 |
| 16 |
Kang C, Sang Q, Liu D, et al. Polyphyllin I alleviates neuroinflammation after cerebral ischemia-reperfusion injury via facilitating autophagy-mediated M2 microglial polarization[J]. Mol Med, 2024, 30 (1): 59.
doi: 10.1186/s10020-024-00828-5 |
| 17 |
Li Y, Liao J, Xiong L, et al. Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic stroke[J]. J Control Release, 2024, 368, 607- 622.
doi: 10.1016/j.jconrel.2024.02.039 |
| 18 |
Naito MG, Xu D, Amin P, et al. Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke[J]. Proc Natl Acad Sci U S A, 2020, 117 (9): 4959- 4970.
doi: 10.1073/pnas.1916427117 |
| 19 |
Tsuchiya K, Nakajima S, Hosojima S, et al. Caspase-1 initiates apoptosis in the absence of gasdermin D[J]. Nat Commun, 2019, 10 (1): 2091.
doi: 10.1038/s41467-019-09753-2 |
| 20 |
Broz P. Pyroptosis: molecular mechanisms and roles in disease[J]. Cell Res, 2025, 35 (5): 334- 344.
doi: 10.1038/s41422-025-01107-6 |
| 21 |
Li C, Luo YP, Li SG. Mechanistic insights of neuronal death and neuroprotective therapeutic approaches in stroke[J]. Neural Regen Res, 2026, 21 (3): 869- 886.
doi: 10.4103/NRR.NRR-D-24-01324 |
| 22 |
Tao XF, Wu Y, Guo FY, et al. Targeted inhibitors of S100A9 alleviate chronic pancreatitis by inhibiting M2 macrophage polarization via the TAOK3-JNK signaling pathway[J]. Front Immunol, 2025, 16, 1526813.
doi: 10.3389/fimmu.2025.1526813 |
| 23 |
Zhi YQ, Zhou XK, Yu JR, et al. Pathophysiological significance of WDR62 and JNK signaling in human diseases[J]. Front Cell Dev Biol, 2021, 9, 640753.
doi: 10.3389/fcell.2021.640753 |
| 24 |
Zhang WQ, Sun HY, Zhao WX, et al. Suppression of JNK pathway protects neurons from oxidative injury via attenuating parthanatos in glutamate-treated HT22 neurons[J]. Sci Rep, 2024, 14 (1): 25793.
doi: 10.1038/s41598-024-76640-2 |
| 25 |
Zhao YY, Kuca K, Wu W, et al. Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases[J]. Alzheimers Dement, 2022, 18 (1): 152- 158.
doi: 10.1002/alz.12370 |
| 26 |
Haeusgen W, Herdegen T, Waetzig V. The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7[J]. Eur J Cell Biol, 2011, 90 (6-7): 536- 544.
doi: 10.1016/j.ejcb.2010.11.008 |
| 27 |
Vogler M, Braun Y, Smith VM, et al. The Bcl-2 family: from apoptosis mechanisms to new advances in targeted therapy[J]. Signal Transduct Target Ther, 2025, 10 (1): 91.
doi: 10.1038/s41392-025-02176-0 |
| 28 |
Yao Q, Wu XH, Tao C, et al. Osteoarthritis: pathogenic signaling pathways and therapeutic targets[J]. Signal Transduct Target Ther, 2023, 8 (1): 56.
doi: 10.1038/s41392-023-01330-w |
| 29 |
Ding D, Liu G, Yan J, et al. Curcumin alleviates osteoarthritis in mice by suppressing osteoclastogenesis in subchondral bone via inhibiting NF-κB/JNK signaling pathway[J]. PLoS One, 2024, 19 (9): e0309807.
doi: 10.1371/journal.pone.0309807 |
| 30 |
Giordano F, Comità S, Venneri G, et al. Poncirus trifoliata (L. ) Raf. seed extract induces cell cycle arrest and apoptosis in the androgen receptor positive LNCaP prostate cancer cells[J]. Int J Mol Sci, 2023, 24 (22): 16351.
doi: 10.3390/ijms242216351 |
| 31 |
Wei K, Zhu WR, Kou YN, et al. Advances in small molecular agents against oral cancer[J]. Molecules, 2024, 29 (7): 1594.
doi: 10.3390/molecules29071594 |
| 32 |
Roy PK, Rashid F, Bragg J, et al. Role of the JNK signal transduction pathway in inflammatory bowel disease[J]. World J Gastroenterol, 2008, 14 (2): 200- 202.
doi: 10.3748/wjg.14.200 |
| 33 | Fujishita T, Aoki M, Taketo MM. JNK signaling promotes intestinal tumorigenesis through activation of mTOR complex 1 in ApcΔ716 mice [J]. Gastroenterology, 2011, 140(5): 1556-1563. e6. |
| 34 |
Tsukui D, Kimura Y, Kono H. GM-CSF receptor/SYK/JNK/FOXO1/CD11c signaling promotes atherosclerosis[J]. iScience, 2023, 26 (8): 107293.
doi: 10.1016/j.isci.2023.107293 |
| 35 |
Sun L, Tu JX, Chen XW, et al. JNK pathway-associated phosphatase associates with rheumatoid arthritis risk, disease activity, and its longitudinal elevation relates to etanercept treatment response[J]. J Clin Lab Anal, 2021, 35 (4): e23709.
doi: 10.1002/jcla.23709 |
| 36 |
Zeke A, Misheva M, Reményi A, et al. JNK signaling: regulation and functions based on complex protein-protein partnerships[J]. Microbiol Mol Biol Rev, 2016, 80 (3): 793- 835.
doi: 10.1128/MMBR.00043-14 |
| 37 |
Hu W, Wu X, Yu D, et al. Regulation of JNK signaling pathway and RIPK3/AIF in necroptosis-mediated global cerebral ischemia/reperfusion injury in rats[J]. Exp Neurol, 2020, 331, 113374.
doi: 10.1016/j.expneurol.2020.113374 |
| 38 |
Zhang HT, Liu HG, Wang YX, et al. Remifentanil preconditioning alleviating brain damage of cerebral ischemia reperfusion rats by regulating the JNK signal pathway and TNF-α/TNFR1 signal pathway[J]. Mol Biol Rep, 2013, 40 (12): 6997- 7006.
doi: 10.1007/s11033-013-2819-5 |
| 39 |
Luo SY, Li R, Le ZY, et al. Anfibatide protects against rat cerebral ischemia/reperfusion injury via TLR4/JNK/caspase-3 pathway[J]. Eur J Pharmacol, 2017, 807, 127- 137.
doi: 10.1016/j.ejphar.2017.04.002 |
| 40 |
Chen W, Zhou X, Meng M, et al. Hyperbaric oxygen improves cerebral ischemia-reperfusion injury in rats via inhibition of ferroptosis[J]. J Stroke Cerebrovasc Dis, 2023, 32 (12): 107395.
doi: 10.1016/j.jstrokecerebrovasdis.2023.107395 |
| 41 |
Zhang SC, Zou W, Leng Y, et al. Neuroprotective effects of metformin on cerebral ischemia-reperfusion injury: modulation of JNK and p38 MAP kinase signaling pathways[J]. Cell Biochem Biophys, 2024, 82 (3): 2597- 2606.
doi: 10.1007/s12013-024-01373-y |
| 42 |
Lai TNH, Herent MF, Quetin-Leclercq J, et al. Piceatannol, a potent bioactive stilbene, as major phenolic component in Rhodomyrtus tomentosa[J]. Food Chem, 2013, 138 (2-3): 1421- 1430.
doi: 10.1016/j.foodchem.2012.10.125 |
| 43 |
Rajan RK, Kumar RP, Ramanathan M. Piceatannol improved cerebral blood flow and attenuated JNK3 and mitochondrial apoptotic pathway in a global ischemic model to produce neuroprotection[J]. Naunyn Schmiedebergs Arch Pharmacol, 2024, 397 (1): 479- 496.
doi: 10.1007/s00210-023-02616-0 |
| 44 |
Wen XR, Tang M, Qi DS, et al. Butylphthalide suppresses neuronal cells apoptosis and inhibits JNK-caspase3 signaling pathway after brain ischemia/reperfusion in rats[J]. Cell Mol Neurobiol, 2016, 36 (7): 1087- 1095.
doi: 10.1007/s10571-015-0302-7 |
| 45 |
Xu D, Kong T, Cheng B, et al. Orexin-A alleviates cerebral ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress-mediated apoptosis[J]. Mol Med Rep, 2021, 23 (4): 266.
doi: 10.3892/mmr.2021.11905 |
| 46 |
Zhang J, Zhou R, Xiang C, et al. Enhanced thioredoxin, glutathione and Nrf2 antioxidant systems by safflower extract and aceglutamide attenuate cerebral ischaemia/reperfusion injury[J]. J Cell Mol Med, 2020, 24 (9): 4967- 4980.
doi: 10.1111/jcmm.15099 |
| 47 | Park HR, Lee H, Lee JJ, et al. Protective effects of Spatholobi Caulis extract on neuronal damage and focal ischemic stroke/reperfusion injury[J]. Mol Neurobiol, 2018, 55 (6): 4650- 4666. |
| . [J]. 2018, 55 (6): 4650- 4666. | |
| 48 |
Pan Y, Luo X, Gong P. Spatholobi caulis: a systematic review of its traditional uses, chemical constituents, biological activities and clinical applications[J]. J Ethnopharmacol, 2023, 317, 116854.
doi: 10.1016/j.jep.2023.116854 |
| 49 |
Xu BT, Xu JP, Cai NB, et al. Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3β-mediated oxidative stress and IRE1α/TRAF2/JNK pathway[J]. Free Radic Biol Med, 2021, 163, 281- 296.
doi: 10.1016/j.freeradbiomed.2020.12.018 |
| 50 |
Liu L, Fang YQ, Xue ZF, et al. Beta-asarone attenuates ischemia-reperfusion-induced autophagy in rat brains via modulating JNK, p-JNK, Bcl-2 and Beclin 1[J]. Eur J Pharmacol, 2012, 680 (1-3): 34- 40.
doi: 10.1016/j.ejphar.2012.01.016 |
| 51 |
Guo Z, Cao G, Yang H, et al. A combination of four active compounds alleviates cerebral ischemia-reperfusion injury in correlation with inhibition of autophagy and modulation of AMPK/mTOR and JNK pathways[J]. J Neurosci Res, 2014, 92 (10): 1295- 1306.
doi: 10.1002/jnr.23400 |
| 52 |
Song NN, Zhao Y, Sun C, et al. DUSP10 alleviates ischemic stroke-induced neuronal damage by restricting p38/JNK pathway[J]. Behav Brain Res, 2023, 450, 114478.
doi: 10.1016/j.bbr.2023.114478 |
| 53 |
Chen SC, Shao LQ, Ma L. Cerebral edema formation after stroke: emphasis on blood-brain barrier and the lymphatic drainage system of the brain[J]. Front Cell Neurosci, 2021, 15, 716825.
doi: 10.3389/fncel.2021.716825 |
| 54 |
Menounos S, Shen H, Tipirneni S, et al. Decoding the nexus: cellular and molecular mechanisms linking stroke and neurotoxic microenvironments in brain cancer patients[J]. Biomolecules, 2024, 14 (12): 1507.
doi: 10.3390/biom14121507 |
| 55 |
Lee YC, Kao ST, Cheng CY. Acorus tatarinowii Schott extract reduces cerebral edema caused by ischemia-reperfusion injury in rats: involvement in regulation of astrocytic NKCC1/AQP4 and JNK/iNOS-mediated signaling[J]. BMC Complement Med Ther, 2020, 20, 374.
doi: 10.3389/fncel.2022.922181 |
| 56 |
Zhu CM, Wang DL, Chang C, et al. Dexmedetomidine alleviates blood-brain barrier disruption in rats after cerebral ischemia-reperfusion by suppressing JNK and p38 MAPK signaling[J]. Korean J Physiol Pharmacol, 2024, 28 (3): 239- 252.
doi: 10.4196/kjpp.2024.28.3.239 |
| 57 |
Li F, Zhou FF, Yang BB. MicroRNA152-3p protects against ischemia/reperfusion-induced BBB destruction possibly targeting the MAP3K2/JNK/c-Jun pathway[J]. Neurochem Res, 2023, 48 (5): 1293- 1304.
doi: 10.1007/s11064-022-03828-1 |
| 58 |
Younis NS, Mohamed ME. Anethole pretreatment modulates cerebral ischemia/reperfusion: the role of JNK, p38, MMP-2 and MMP-9 pathways[J]. Pharmaceuticals (Basel), 2023, 16 (3): 442.
doi: 10.3390/ph16030442 |
| 59 |
Raposo A, Raheem D, Zandonadi RP, et al. Anethole in cancer therapy: mechanisms, synergistic potential, and clinical challenges[J]. Biomed Pharmacother, 2024, 180, 117449.
doi: 10.1016/j.biopha.2024.117449 |
| 60 |
Jurcau A, Simion A. Neuroinflammation in cerebral ischemia and ischemia/reperfusion injuries: from pathophysiology to therapeutic strategies[J]. Int J Mol Sci, 2021, 23 (1): 14.
doi: 10.1186/s13020-021-00495-2 |
| 61 |
许威, 彭涛, 曾梦柳. A1型星形胶质细胞: 治疗神经退行性和神经炎性疾病的新靶点[J]. 实用医学杂志, 2023, 39 (23): 3143- 3148.
doi: 10.3969/j.issn.1006-5725.2023.23.021 |
| 62 |
Cheng CY, Chiang SY, Kao ST, et al. Alpinia oxyphylla Miq extract reduces cerebral infarction by downregulating JNK-mediated TLR4/T3JAM- and ASK1-related inflammatory signaling in the acute phase of transient focal cerebral ischemia in rats[J]. Chin Med, 2021, 16 (1): 82.
doi: 10.3390/ijms23010014 |
| 63 |
Cai J, Liang J, Zhang Y, et al. Cyclo-(Phe-Tyr) as a novel cyclic dipeptide compound alleviates ischemic/reperfusion brain injury via JUNB/JNK/NF-κB and SOX5/PI3K/AKT pathways[J]. Pharmacol Res, 2022, 180, 106230.
doi: 10.1016/j.phrs.2022.106230 |
| 64 |
Wang G, Chen Z, Song Y, et al. Xueshuantong injection alleviates cerebral microcirculation disorder in middle cerebral artery occlusion/reperfusion rats by suppressing inflammation via JNK mediated JAK2/STAT3 and NF-κB signaling pathways[J]. J Ethnopharmacol, 2022, 298, 115592.
doi: 10.1016/j.jep.2022.115592 |
| 65 |
Zhu Y, Li S, Liu J, et al. Role of JNK signaling pathway in dexmedetomidine post-conditioning-induced reduction of the inflammatory response and autophagy effect of focal cerebral ischemia reperfusion injury in rats[J]. Inflammation, 2019, 42 (6): 2181- 2191.
doi: 10.1007/s10753-019-01082-2 |
| 66 |
Zheng XF, Zhang XJ, Dong L, et al. Neuroprotective mechanism of salvianolic acid B against cerebral ischemia-reperfusion injury in mice through downregulation of TLR4, p-p38MAPK, p-JNK, NF-κB, and IL-1β[J]. Immun Inflamm Dis, 2023, 11 (10): e1030.
doi: 10.1002/iid3.1030 |
| 67 |
Zhang ZY, Wang L, Wang Z, et al. Lysosomal-associated transmembrane protein 5 deficiency exacerbates cerebral ischemia/reperfusion injury[J]. Front Mol Neurosci, 2022, 15, 971361.
doi: 10.3389/fnmol.2022.971361 |
| 68 |
Xu L, Li Y, Fu Q, et al. Perillaldehyde attenuates cerebral ischemia-reperfusion injury-triggered overexpression of inflammatory cytokines via modulating Akt/JNK pathway in the rat brain cortex[J]. Biochem Biophys Res Commun, 2014, 454 (1): 65- 70.
doi: 10.1016/j.bbrc.2014.10.025 |
| 69 |
Yang TY, Wu J, Ge K, et al. MicroRNA-193b-3p reduces oxidative stress and mitochondrial damage in rats with cerebral ischemia-reperfusion injury via the seven in absentia homolog 1/Jun N-terminal kinase pathway[J]. Bioengineered, 2022, 13 (3): 6942- 6954.
doi: 10.1080/21655979.2022.2036398 |
| [1] | Xinyu ZHANG, Shaowen WEN, Fei ZHAO, Lili WU, Jionglu ZHANG, Zehai FANG, Hongjie LIU. Gastrodin attenuates 6-hydroxydopamine-induced apoptosis in PC12 cells by modulating the PI3K signaling pathway and reducing reactive oxygen species levels [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(9): 1153-1161. |
| [2] | Yimeng FANG, Xinyi LEI, Sihan MA, Wenbo SHI, Luze CEN, Manyun DAI. Mechanism study on the liver cell damage induced by triptolide through activating the JNK pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(8): 1027-1033. |
| [3] | Qi LOU, Anran GUO, Shuting YUAN, Ting WANG, Huiyu JIA, Xiaoyu ZHU, Dongmei YANG, Manqin YANG, Shengyong LUO. The mechanism of Qihong Tongluo Granule in regulating mitochondrial dynamics disorder and improving cerebral ischemia-reperfusion injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(10): 1320-1329. |
| [4] | LI Yanfei1, HUANG Can2, LUO Ping3, HE Fang4, HU Changping2. LOX-1 promotes hypoxia-induced autophagy and apoptosis in endothelial cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(8): 1017-1025. |
| [5] | LIU Dewei, WU Dong, HUANG Dan, ZHAO Xuanna, WU Bin. Research progress on non-coding RNA mediated apoptosis in lung cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 968-976. |
| [6] | GAO Wanli, ZHOU Qichun, WANG Sumei. Fructus Akebiae induces apoptosis via regulating ROS-mediated PI3K-Akt signaling pathway in non-small cell lung cancer cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 339-346. |
| [7] | LIU Jing, HOU Kai, ZHANG Li. Improvement of non-alcoholic steatohepatitis by Butein and research on its mechanism [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 355-365. |
| [8] | XIA Rongsong, YANG Jing, WANG Hong, PENG Zhe, ZHAO Yibei, YANG Junqing. Nrf1 attenuates neuronal injury caused by oxygen glucose deprivation/reperfusion via inhibiting apoptosis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(1): 11-19. |
| [9] | SONG Xiaoping, LIU Pingping, LIU Xiaolin, ZHENG Yan, SUN Bin, DING Jian, ZHU Yuanqi, LI Junfeng. Effects of emodin on autophagy and apoptosis in rats with severe pneumonia caused by Klebsiella pneumoniae by regulating SIRT1/AMPK signaling pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(1): 42-50. |
| [10] | KE Jiajie, SHEN Yuzhou, XU Yaping, CHEN Yupei, CHEN Peiyuan, WU Hongtan. Effects and mechanism of ethanol extract of Angelica sinensis (Oliv.) Diels on cell proliferation inhibition and apoptosis induction in B16-F10 melanoma cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(1): 51-60. |
| [11] | LEI Guojie, YU Yanhua, LIU Yingchao, BIAN Wenxia, DU Jing, TONG Xiangmin. Mechanism of PX-12 induced apoptosis of hepatocellular carcinoma cells through oxidative stress [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 961-967. |
| [12] | ZHANG Jianxin, YANG Xiaolai. Glycyrrhizin inhibits the neurotoxic effects and mechanisms induced by morphine [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 554-560. |
| [13] | HUANG Xiaomei, ZHI Hui, CHEN Hao, LU Linming, ZHU Xiaoqun, WANG Lizhen, ZHOU Jue, PANG Jinjin, XU Jinliang. Effects of the proliferation, migration and apoptosis of AHVAC-Ⅰ on gastric cancer MKN-28 cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 270-276. |
| [14] | ZHUANG Min, XIE Qianlong, TAN Lingfang, ZHUANG Jie, SUI Yuxia. Hesperetin induces apoptosis in gefitinib-resistant NCI-H1975 cells through ROS mediated endoplasmic reticulum stress [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(11): 1220-1231. |
| [15] | PANG Lili, HU Ying, LUO Jie, TU Qin, CHEN Min. Study of the mechanism of combretastatin a-4 derivative LGD5 induced G2/M cycle arrest and apoptosis in human cervical cancer HeLa cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(10): 1100-1109. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||